Koers Wildflower Brands Inc. Canadian Securities Exchange
Aandelen
SUN
CA96812N1050
Farmaceutische producten
Omzet 2018 | 1,41 1,93 1,31 | Omzet 2019 | 7,09 9,7 6,58 | Marktkapitalisatie | 63,9 mln. 87,44 mln. 59,38 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2018 | -7 mln. -9,58 mln. -6,51 mln. | Nettowinst (verlies) 2019 | -4 mln. -5,47 mln. -3,72 mln. | EV/omzet 2018 | 44.908.398 x |
Nettoschuld 2018 | 7,85 mln. 10,75 mln. 7,3 mln. | Nettoschuld 2019 | 7,32 mln. 10,01 mln. 6,8 mln. | EV/omzet 2019 | 10.051.719 x |
K/w-verhouding 2018 |
-6,99
x | K/w-verhouding 2019 |
-6,61
x | Werknemers | - |
Dividendrendement 2018 * |
-
| Dividendrendement 2019 |
-
| Vrij verhandelbaar | 100% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
William MacLean
CEO | Chief Executive Officer | - | 18-06-14 |
Stephen Pearce
DFI | Director of Finance/CFO | 54 | 30-08-13 |
Myron van Snick
COO | Chief Operating Officer | - | 13-04-20 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Stephen Pearce
DFI | Director of Finance/CFO | 54 | 30-08-13 |
William MacLean
CEO | Chief Executive Officer | - | 18-06-14 |
Director/Board Member | - | 06-04-18 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+39,33% | 6,11 mld. | |
-18,38% | 4,35 mld. | |
-9,17% | 3,19 mld. | |
+3,98% | 3,15 mld. | |
-3,41% | 2,51 mld. | |
+48,74% | 1,98 mld. | |
-4,82% | 1,74 mld. | |
-1,24% | 1,63 mld. | |
-8,96% | 1,6 mld. |